Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi L Kenerson

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Cell Reports|January 18, 2024
Recruitment of BAG2 to DNAJ-PKAc scaffolds promotes cell survival and resistance to drug-induced apoptosis in fibrolamellar carcinomaSophia M Lauer, Mitchell H Omar, Martin G Golkowski, et al.
Frontiers in Immunology|March 31, 2022
Response of Human Liver Tissue to Innate Immune StimuliXia Wu, Jessica B Roberto, Allison Knupp, et al.
Elife|May 8, 2019
An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinomaRigney E Turnham, F Donelson Smith, Heidi L Kenerson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2021
Glypican-3-Targeted <sup>227</sup>Th <b>α</b>-Therapy Reduces Tumor Burden in an Orthotopic Xenograft Murine Model of Hepatocellular CarcinomaKevin P Labadie, Donald K Hamlin, Aimee Kenoyer, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
Mitochondrial Calcium Signaling Regulates Branched-Chain Amino Acid Catabolism in Fibrolamellar CarcinomaNicole M Marsh, Melissa J S MacEwen, Jane Chea, et al.
Science Translational Medicine|May 15, 2024
SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinomaIris S Luk, Caroline M Bridgwater, Angela Yu, et al.
Gut|June 15, 2022
Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastasesKevin M Sullivan, Xiuyun Jiang, Prajna Guha, et al.
Elife|January 24, 2023
Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanismsGary K L Chan, Samantha Maisel, Yeonjoo C Hwang, et al.
Cancer Immunology Research|November 7, 2025
Intratumoral three-cell-type clusters are a conserved feature of endogenous antitumor immunitySheela R Damle, Jason A Carter, Kristin E Goodsell, et al.
Gastroenterology|February 17, 2026
Overcoming CXCR4-Mediated T-Cell Exclusion Potentiates Antitumor Cytotoxicity in Fibrolamellar CarcinomaJason A Carter, Lindsay K Dickerson, Andreas Stephanou, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cell Reports|January 18, 2024
Recruitment of BAG2 to DNAJ-PKAc scaffolds promotes cell survival and resistance to drug-induced apoptosis in fibrolamellar carcinomaSophia M Lauer, Mitchell H Omar, Martin G Golkowski, et al.
Frontiers in Immunology|March 31, 2022
Response of Human Liver Tissue to Innate Immune StimuliXia Wu, Jessica B Roberto, Allison Knupp, et al.
Elife|May 8, 2019
An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinomaRigney E Turnham, F Donelson Smith, Heidi L Kenerson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2021
Glypican-3-Targeted <sup>227</sup>Th <b>α</b>-Therapy Reduces Tumor Burden in an Orthotopic Xenograft Murine Model of Hepatocellular CarcinomaKevin P Labadie, Donald K Hamlin, Aimee Kenoyer, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
Mitochondrial Calcium Signaling Regulates Branched-Chain Amino Acid Catabolism in Fibrolamellar CarcinomaNicole M Marsh, Melissa J S MacEwen, Jane Chea, et al.
Science Translational Medicine|May 15, 2024
SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinomaIris S Luk, Caroline M Bridgwater, Angela Yu, et al.
Gut|June 15, 2022
Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastasesKevin M Sullivan, Xiuyun Jiang, Prajna Guha, et al.
Elife|January 24, 2023
Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanismsGary K L Chan, Samantha Maisel, Yeonjoo C Hwang, et al.
Cancer Immunology Research|November 7, 2025
Intratumoral three-cell-type clusters are a conserved feature of endogenous antitumor immunitySheela R Damle, Jason A Carter, Kristin E Goodsell, et al.
Gastroenterology|February 17, 2026
Overcoming CXCR4-Mediated T-Cell Exclusion Potentiates Antitumor Cytotoxicity in Fibrolamellar CarcinomaJason A Carter, Lindsay K Dickerson, Andreas Stephanou, et al.
Pageof 4